BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/21/2025 12:30:05 PM | Browse: 2 | Download: 0
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Observational Study |
Article Title |
MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Asad Izziddin Dajani, Branko Popovic, Caroline Amand, Sabine Tong, Kirill Maximovich Starostin and Victor Goncharuk |
Funding Agency and Grant Number |
|
Corresponding Author |
Branko Popovic, MD, Global Medical Affairs, A. Nattermann & Cie. GmbH, Aqua Tower, Junghofstraße 9, Frankfurt am Main 60315, Germany. branko.popovic@sanofi.com |
Key Words |
Algorithms; Essential phospholipids; Liver enzymes; Non-alcoholic fatty liver disease; Ultrasonography |
Core Tip |
Essentiale Forte N®, administered as adjunctive therapy in patients with non-alcoholic fatty liver disease (NAFLD), reduced liver enzyme levels [alanine transaminase (ALT), aspartate transaminase (AST) and gamma-glutamyl transferase (GGT)] and improved ultrasonographic features of NAFLD, particularly with regard to liver hyperechogenicity and structure, with a greater reduction noted with increasing NAFLD severity. These data indicate that Essentiale, alone or in combination with other treatment, is effective for the management of NAFLD. Additionally, a non-invasive diagnostic algorithm based on the statistical distribution of three liver enzymes (ALT, AST, and GGT) could be used to increase the accuracy of diagnosis, staging, and monitoring of patients with NAFLD. |
Citation |
Dajani AI, Popovic B, Amand C, Tong S, Starostin KM, Goncharuk V. MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry. World J Hepatol 2025; In press |
 |
Received |
|
2024-11-13 10:18 |
 |
Peer-Review Started |
|
2024-11-21 03:50 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-01-10 03:23 |
 |
Revised |
|
2025-03-10 14:44 |
 |
Second Decision |
|
2025-05-19 02:45 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-21 12:30 |
 |
Articles in Press |
|
2025-05-21 12:30 |
 |
Publication Fee Transferred |
|
2025-03-19 10:31 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345